Anthem Blue Cross Blue Shield of California policy

CG-MED-81 Ultrasound Ablation for Oncologic Indications

CG-MED-81 Ultrasound Ablation for Oncologic Indications is a public Anthem Blue Cross Blue Shield of California policy (policy CG-MED-81). It lists 7 CPT or HCPCS codes, 7 of them on the Anthem Blue Cross Blue Shield of California prior authorization list. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Check eligibility for free

No account required. Sign a BAA to see plan details, coordination of benefits and more

Payer
Anthem Blue Cross Blue Shield of California
Policy number
CG-MED-81
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of California prior authorization list.

CodePrior authorizationDescription on the prior authorization listOther Anthem Blue Cross Blue Shield of California policies
19499On the listUnlisted procedure, breast [when specified as destruction of breast tissue by high intensity focused ultrasound] or [when specified as radiofrequency or microwave ablation or laser ablation of breast tumor(s)] or [when specified as catheter lavage of a mammary duct or fiberoptic ductoscopy]Policies naming 19499
20999On the listUnlisted procedure, musculoskeletal system, general [when specified as high intensity focused ultrasound for pain palliation for bone metastases] or [No specific code for surgery using Coblation technology] or [when specified as radiofrequency or pulsed radiofrequency treatment of trigger points] or [when specified as percutaneous ultrasonic ablation of soft tissue] or [when specified as harvesting and injection of bone marrow aspirate concentrate or harvesting or administration of stem cells for therapy to repair damaged cells or body tissues]Policies naming 20999
51721On the listInsertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation, including suprapubic tube placement during the same session and placement of an endorectal cooling device, when performedPolicies naming 51721
55880On the listAblation of malignant prostate tissue, transrectal, with high intensity-focused ultrasound (HIFU), including ultrasound guidancePolicies naming 55880
55881On the listAblation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablationPolicies naming 55881
55882On the listAblation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation; with insertion of transurethral ultrasound transducer for delivery of thermal ultrasound, including suprapubic tube placement and placement of an endorectal cooling device, when performedPolicies naming 55882
C9734On the listFocused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with or without magnetic resonance (MR) guidancePolicies naming C9734

All Anthem Blue Cross Blue Shield of California policies · Anthem Blue Cross Blue Shield of California prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.